Gsk (GSK) Debt Ratio (2009 - 2026)

Gsk (GSK) has 18 years of Debt Ratio data on file, last reported at 0.38 in Q2 2026.

• For the quarter ending Q2 2026, Debt Ratio changed 0.45% year-over-year to 0.38; the trailing twelve-month figure through Jun 2026 stood at 0.38 (changed 0.45% YoY), and the FY2025 full-year result was 0.38, up 2.66% from the prior year.
• Debt Ratio was 0.38 for Q2 2026 at Gsk, up from 0.39 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.31 in Q2 2022 to a low of 0.47 in Q3 2022.
• A 5-year average of 0.4 and a median of 0.39 in 2024 frame the typical range for Debt Ratio.
• Across the five-year window, Debt Ratio grew 21.79% in 2022 and sank 45.25% in 2023, its largest moves.
• Gsk's Debt Ratio stood at 0.45 in 2022, then advanced by 10.02% to 0.4 in 2023, then climbed by 3.01% to 0.39 in 2024, then grew by 2.66% to 0.38 in 2025, then declined by 1.3% to 0.38 in 2026.
• Per Business Quant data, the three most recent Debt Ratio figures were 0.38 in Q2 2026, 0.39 in Q1 2026, and 0.38 in Q4 2025.